Tirzepatide for Partial Lipodystrophy Treatment: A New Horizon in 2024

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Tirzepatide for Partial Lipodystrophy Treatment: A New Horizon in 2024	acquired partial lipodystrophy	Recruiting	Phase 2	2025-09-09		NCT07091734

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University of Michigan	394

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University of Michigan	Ann Arbor	United States	538

Clinical trials